Top Stories

ROI for cataracts tops interventions list

Staff reporters 18/03/2024

A Fred Hollows Foundation report shows the return on investment (ROI) for eye disease interventions are among the highest of any disease

The damage that drops can do!

Dr Alex Ioannidis 14/03/2024

Ocular surface disease management in glaucomatous patients is important to reduce further ocular morbidity, writes Dr Alex Ioannidis

Transforming eyecare with AI

Staff reporters 15/03/2024

AI in eyecare will play an important role in alleviating future public health challenges, says Dr Pearse Keane, Moorfields consultant and professor of artificial medical intelligence at UCL

Myopia management applications

Grant Hannaford 14/03/2024

Myopia management has developed into a significant segment of clinical practice in recent years, writes Grant Hannaford

News

Cell-clearance drug combats DMO

Staff reporters 19/03/2024

A bold declaration of style

Staff reporters 19/03/2024

OCT’s role in angioedema care

Staff reporters 18/03/2024

Colourful Colorado

Staff reporters 18/03/2024

Home lighting boosts seniors’ activity

Staff reporters 17/03/2024

Blue eyes see better in the dark

Staff reporters 16/03/2024

Blackfin brilliance

Staff reporters 16/03/2024

Editor's Choice

Neglecting climate change at our peril

Dr Belinda Mathers 14/03/2024

GNZ’s lessons in drop adherence

Esther Kim 12/03/2024

Regarding menopause and eye health

Layal Naji 08/03/2024

Atropine drops approved for NZ

Drew Jones 06/03/2024

Features

The complex diagnosis of intraocular lymphoma

Drs James Brodie, Laura Butler and Rachael Niederer 02/03/2024

As easy as riding a bike

David Slack 18/02/2024

Comment

Retina research review: DR, GA and PAMM

Dr Francesc March de Ribot 01/03/2024

LETTER: optometrists’ use of the ‘Dr’ title

Kristine Hammond and Elmarie Stander 26/02/2024